Zealand Pharma A/S (ZLDPF)
OTCMKTS
· Delayed Price · Currency is USD
84.50
-1.50 (-1.74%)
Mar 14, 2025, 4:00 PM EST
Zealand Pharma Employees
Zealand Pharma had 335 employees as of December 31, 2024. The number of employees increased by 82 or 32.41% compared to the previous year.
Employees
335
Change (1Y)
82
Growth (1Y)
32.41%
Revenue / Employee
$25,979
Profits / Employee
-$447,060
Market Cap
5.98B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
Silence Therapeutics | 116 |
Longduoduo Company | 49 |
Zealand Pharma News
- 16 hours ago - Zealand Pharma announces completion of enrollment in the Phase 2b ZUPREME-1 trial of petrelintide in people with overweight or obesity - GlobeNewsWire
- 5 days ago - Roche, Zealand Pharma Strike $5.3 Billion Weight-Loss Therapy Deal - The Wall Street Journal
- 5 days ago - Roche agrees biggest-ever obesity drug deal - Financial Times
- 5 days ago - Roche Inks 'The Largest Obesity Deal To Date' With Zealand Pharma At $5.3 Billion - Investor's Business Daily
- 5 days ago - Roche And Zealand Team Up To Develop Petrelintide - Seeking Alpha
- 5 days ago - Roche Further Boosts Obesity Pipeline With Zealand Pharma Deal Worth $5.3 Billion For Weight Loss Drugs - Benzinga
- 5 days ago - New drug candidate will help people lose weight in an easier way, Zealand Pharma CEO says - CNBC
- 5 days ago - Roche, Zealand Pharma in $5.3 billion pact for obesity drugs - Fortune